Li H, Nemeth A, Melander R, Melander C
ACS Infect Dis. 2024; 10(4):1339-1350.
PMID: 38491938
PMC: 11780689.
DOI: 10.1021/acsinfecdis.4c00026.
Sealey J, Hammond A, Reyher K, Avison M
One Health. 2023; 17:100640.
PMID: 38024284
PMC: 10665141.
DOI: 10.1016/j.onehlt.2023.100640.
Wei Y, Ji X, Zhang F, Zhang S, Deng Q, Ding H
Front Pharmacol. 2023; 14:1226936.
PMID: 37869750
PMC: 10587432.
DOI: 10.3389/fphar.2023.1226936.
Abdallah E, Alhatlani B, Menezes R, Martins C
Plants (Basel). 2023; 12(17).
PMID: 37687324
PMC: 10490416.
DOI: 10.3390/plants12173077.
Correia J, Borges A, Simoes M, Simoes L
Antibiotics (Basel). 2023; 12(8).
PMID: 37627670
PMC: 10451904.
DOI: 10.3390/antibiotics12081250.
Effect of four fluoroquinolones on the viability of bladder cancer cells in 2D and 3D cultures.
Kloskowski T, Fekner Z, Szeliski K, Paradowska M, Balcerczyk D, Rasmus M
Front Oncol. 2023; 13:1222411.
PMID: 37534254
PMC: 10390741.
DOI: 10.3389/fonc.2023.1222411.
Epidemiological links and antimicrobial resistance of clinical ST198 isolates: a nationwide microbial population genomic study in Switzerland.
Biggel M, Horlbog J, Nuesch-Inderbinen M, Chattaway M, Stephan R
Microb Genom. 2022; 8(10).
PMID: 36301086
PMC: 9676052.
DOI: 10.1099/mgen.0.000877.
Effects of Ciprofloxacin Alone or in Mixture with Sulfamethoxazole on the Efficiency of Anaerobic Digestion and Its Microbial Community.
Mazzurco Miritana V, Patrolecco L, Caracciolo A, Visca A, Piccinini F, Signorini A
Antibiotics (Basel). 2022; 11(8).
PMID: 36009981
PMC: 9404932.
DOI: 10.3390/antibiotics11081111.
Genotypic antimicrobial resistance characterization of E. coli from dairy calves at high risk of respiratory disease administered enrofloxacin or tulathromycin.
Pereira R, Foditsch C, Siler J, Duliepre S, Altier C, Garzon A
Sci Rep. 2020; 10(1):19327.
PMID: 33168881
PMC: 7653923.
DOI: 10.1038/s41598-020-76232-w.
Oral Plus Topical Administration of Enrofloxacin-Hydrochloride-Dihydrate for the Treatment of Unresponsive Canine Pyoderma. A Clinical Trial.
Gutierrez L, Tapia G, Ocampo L, Monroy-Barreto M, Sumano H
Animals (Basel). 2020; 10(6).
PMID: 32485942
PMC: 7341524.
DOI: 10.3390/ani10060943.
Outpatient Clinical Trial in Dogs With Leptospirosis Treated With Enrofloxacin Hydrochloride-Dihydrate (ENRO-C).
Gutierrez L, Mendoza J, Rangel A, Tapia G, Bernad M, Sumano H
Front Vet Sci. 2019; 6:360.
PMID: 31681813
PMC: 6803455.
DOI: 10.3389/fvets.2019.00360.
Determination of two fluoroquinolones and their combinations with hyaluronan effect in canine cartilage explants.
Siengdee P, Pradit W, Chomdej S, Nganvongpanit K
PeerJ. 2019; 7:e6553.
PMID: 30881764
PMC: 6419719.
DOI: 10.7717/peerj.6553.
In vivo pharmacokinetic/Pharmacodynamic modeling of Enrofloxacin against Escherichia coli in broiler chickens.
Xiao X, Jiang L, Lan W, Jiang Y, Wang Z
BMC Vet Res. 2018; 14(1):374.
PMID: 30497453
PMC: 6267815.
DOI: 10.1186/s12917-018-1698-3.
Efficacy of Triple Antibiotic Paste, Moxifloxacin, Calcium Hydroxide And 2% Chlorhexidine Gel In Elimination of : An In vitro Study.
Lakhani A, Sekhar K, Gupta P, Tejolatha B, Gupta A, Kashyap S
J Clin Diagn Res. 2017; 11(1):ZC06-ZC09.
PMID: 28274034
PMC: 5324479.
DOI: 10.7860/JCDR/2017/22394.9132.
Antimicrobial Use for and Resistance of Zoonotic Bacteria Recovered from Nonhuman Primates.
Kim J, Coble D, Salyards G, Bower J, Rinaldi W, Plauche G
Comp Med. 2017; 67(1):79-86.
PMID: 28222842
PMC: 5310628.
Update in feline therapeutics: clinical use of 10 emerging therapies.
Whitehouse W, Viviano K
J Feline Med Surg. 2015; 17(3):220-34.
PMID: 25701861
PMC: 11148892.
DOI: 10.1177/1098612X15571879.